Intellectual Property Compliance
Taiwan, a WTO member, has been continuously ranked one of the top players in the world in terms of receiving US patents. ScinoPharm, through its Singapore subsidiary, has filed a number of Patent Cooperation Treaty (PCT) patent applications and some of them have been granted for registrations. Our emphasis on intellectual property protection has enabled us to establish successful relationships with many major pharmaceutical companies.
We are committed to strict adherence to United States and international intellectual property standards to protect our own and our customers’ intellectual property rights. All facilities are equipped with physical security equal to U.S. plants, including card-key/electronic monitoring, bound/numbered research notebooks, 24-hour on-site security, video monitoring throughout the plant site, and motion detectors along all perimeter fence lines. In addition to the facilities, we also periodically provide our employees with training programs of intellectual property protection and aim to ensure that all of our employees understand and comply with our intellectual property protection policy.
Our success will depend, in part, on our ability to obtain and enforce patents, protect trade secrets, obtain licenses to technology from our collaborators when necessary, and conduct our business without infringing the proprietary rights of others. We have a policy of seeking patent protection for any patentable proprietary technology. In short, we seek patent protection for the products and processes developed in the course of our research when we believe such protection is in our best interest.
We also provide CRO service to our customers. In most cases, the ownership of proprietary technology developed by us in the course of work performed under the contract is vested in the customers, and we retain little or no ownership.